Aprea Therapeutics (APRE) Short Interest Ratio & Short Volume

$3.35

-0.01 (-0.30%)

(As of 09/6/2024 ET)

Aprea Therapeutics Short Interest Data

Aprea Therapeutics (APRE) has a short interest of 16,700 shares, representing 0.35% of the float (the number of shares available for trading by the public). This marks a 36.89% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 18,467 shares to cover all short positions.

Current Short Interest: 16,700 shares
Previous Short Interest: 12,200 shares
Change Vs. Previous Month: +36.89%
Dollar Volume Sold Short: $56,947.00
Short Interest Ratio: 1.7 Days to Cover
Last Record Date: August 15, 2024

Outstanding Shares: 5,430,000 shares
Float Size: 4,820,000 shares
Short Percent of Float: 0.35%
Today's Trading Volume: 10,158 shares
Average Trading Volume: 18,467 shares
Today's Volume Vs. Average: 55%

Short Selling Aprea Therapeutics?

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Aprea Therapeutics and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

APRE Short Interest Over Time

APRE Days to Cover Over Time

APRE Percentage of Float Shorted Over Time

Ad Weiss Ratings

“Fed Proof” Your Bank Account with THESE 4 Simple Steps

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

Aprea Therapeutics Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
8/15/2024	16,700 shares	$56,947.00	+36.9%	0.4%	1.7	$3.41
7/31/2024	12,200 shares	$45,140.00	-41.4%	0.3%	1.2	$3.70
7/15/2024	20,800 shares	$81,536.00	-6.3%	0.4%	2.3	$3.92
6/30/2024	22,200 shares	$90,354.00	+13.3%	0.5%	2.4	$4.07
6/15/2024	19,600 shares	$86,349.76	-7.6%	0.4%	1.9	$4.41
5/31/2024	21,200 shares	$101,124.00	-34.6%	0.4%	0.7	$4.77
Get the Latest News and Ratings for APRE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
5/15/2024	32,400 shares	$187,920.00	-64.3%	0.7%	1.1	$5.80
4/30/2024	90,700 shares	$462,570.00	-5.7%	1.9%	3	$5.10
4/15/2024	96,200 shares	$570,466.00	-9.1%	2.0%	2.9	$5.93
3/31/2024	105,800 shares	$707,802.00	-9.7%	2.4%	3.1	$6.69
3/15/2024	117,100 shares	$724,849.00	+66.8%	3.8%	3.3	$6.19
2/29/2024	70,200 shares	$593,892.00	-11.6%	2.2%	2.1	$8.46
2/15/2024	79,400 shares	$450,992.00	-20.5%	2.5%	5.6	$5.68
1/31/2024	99,900 shares	$516,483.00	-17.0%	3.2%	7.6	$5.17
1/15/2024	120,300 shares	$671,274.00	+5.7%	3.8%	10.7	$5.58
12/31/2023	113,800 shares	$534,860.00	-1.6%	3.6%	10.4	$4.70
12/15/2023	115,700 shares	$444,288.00	-1.6%	3.7%	11.6	$3.84
11/30/2023	117,600 shares	$428,064.00	-2.4%	3.8%	11.4	$3.64
11/15/2023	120,500 shares	$477,180.00	+4.1%	3.9%	11.4	$3.96
10/31/2023	115,800 shares	$394,878.00	-3.3%	3.7%	9.4	$3.41
10/15/2023	119,700 shares	$629,622.00	+0.9%	3.8%	7.5	$5.26
9/30/2023	118,600 shares	$494,146.90	-5.7%	3.8%	2.6	$4.17
9/15/2023	125,800 shares	$503,200.00	-1.3%	4.0%	2.8	$4.00
8/31/2023	127,500 shares	$470,475.00	-5.0%	4.1%	2.8	$3.69
8/15/2023	134,200 shares	$483,120.00	-9.1%	4.3%	2.8	$3.60
7/31/2023	147,700 shares	$457,870.00	+427.5%	4.7%	3.2	$3.10
7/15/2023	28,000 shares	$87,640.00	+9.4%	0.9%	0.6	$3.13
6/30/2023	25,600 shares	$80,640.00	+161.2%	0.8%	2	$3.15
6/15/2023	9,800 shares	$33,418.00	-58.5%	0.3%	0.7	$3.41
5/31/2023	23,600 shares	$90,860.00	-4.8%	0.8%	1.8	$3.85
5/15/2023	24,800 shares	$90,768.00	-30.3%	0.8%	1.7	$3.66
4/30/2023	35,600 shares	$141,154.00	+20.3%	1.1%	2.3	$3.97
4/15/2023	29,600 shares	$121,360.00	+46.5%	0.9%	2	$4.10
3/31/2023	20,200 shares	$89,688.00	-56.2%	0.6%	1.2	$4.44
3/15/2023	46,100 shares	$240,642.00	+31.0%	1.4%	2.9	$5.22
2/28/2023	35,200 shares	$180,576.00	-3.3%	1.0%	2.5	$5.13
2/15/2023	36,400 shares	$283,920.00	-94.4%	1.9%	2.8	$7.80
1/31/2023	646,700 shares	$324,320.05	-24.3%	N/A	3	$0.50
1/15/2023	854,200 shares	$416,507.92	+6.2%	N/A	4.1	$0.49
12/30/2022	804,300 shares	$266,223.30	+9.9%	N/A	5.7	$0.33
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad) Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late.
12/15/2022	731,700 shares	$278,046.00	-0.8%	N/A	5.7	$0.38
11/30/2022	737,800 shares	$306,187.00	-9.3%	N/A	5	$0.42
11/15/2022	813,300 shares	$333,453.00	-8.2%	N/A	5.4	$0.41
10/31/2022	885,700 shares	$593,330.43	-9.0%	4.5%	7.2	$0.67
10/15/2022	973,700 shares	$740,012.00	+18.5%	5.0%	7	$0.76
9/30/2022	821,800 shares	$534,170.00	-6.1%	4.2%	3.1	$0.65
9/15/2022	875,500 shares	$773,154.05	+24.7%	4.5%	1.2	$0.88
8/31/2022	701,900 shares	$557,378.79	+3.1%	3.6%	1	$0.79
8/15/2022	681,100 shares	$626,612.00	-14.9%	3.5%	0.9	$0.92
7/31/2022	800,200 shares	$768,192.00	-61.5%	4.1%	0.9	$0.96
7/15/2022	2,080,000 shares	$2.33 million	+154.3%	11.8%	2.3	$1.12
6/30/2022	817,900 shares	$613,425.00	-14.7%	4.6%	1	$0.75
6/15/2022	958,400 shares	$797,388.80	-18.1%	5.8%	2.5	$0.83
5/31/2022	1,170,000 shares	$979,875.00	+22.0%	7.1%	2.6	$0.84
5/15/2022	959,100 shares	$1.14 million	+2.1%	5.7%	2.3	$1.19
4/30/2022	939,700 shares	$1.37 million	-9.6%	5.5%	2.9	$1.46
4/15/2022	1,040,000 shares	$1.71 million	+7.3%	6.1%	2.9	$1.64
3/31/2022	969,500 shares	$1.80 million	+11.0%	5.8%	2.6	$1.86
3/15/2022	873,700 shares	$1.52 million	-5.8%	5.2%	2	$1.74
2/28/2022	927,800 shares	$1.61 million	-5.6%	5.6%	1.5	$1.74
2/15/2022	983,000 shares	$1.84 million	+30.8%	5.9%	1.5	$1.87
1/31/2022	751,400 shares	$1.57 million	+35.6%	4.8%	1	$2.09
1/15/2022	554,300 shares	$1.46 million	-17.6%	3.6%	0.7	$2.64
12/31/2021	672,500 shares	$1.93 million	-36.6%	4.3%	0.7	$2.87
12/15/2021	1,060,000 shares	$3.65 million	+43.9%	6.8%	0.9	$3.44
11/30/2021	736,600 shares	$2.98 million	+12.9%	4.8%	0.5	$4.04
11/15/2021	652,200 shares	$3.14 million	-27.2%	4.2%	0.4	$4.82
10/29/2021	895,400 shares	$4.43 million	+7.4%	5.9%	0.6	$4.95
10/15/2021	833,500 shares	$4.28 million	+3.5%	5.5%	0.6	$5.14
9/30/2021	805,300 shares	$4.12 million	+171.0%	5.3%	0.4	$5.11
9/15/2021	297,200 shares	$1.38 million	-57.3%	2.0%	0.2	$4.64
8/31/2021	695,800 shares	$3.21 million	-24.2%	4.6%	0.2	$4.62
8/13/2021	917,400 shares	$3.35 million	-27.2%	6.0%	0.3	$3.65
7/30/2021	1,260,000 shares	$5.33 million	+15.6%	8.5%	0.4	$4.23
7/15/2021	1,090,000 shares	$5.55 million	-42.3%	7.4%	0.3	$5.09
6/30/2021	1,890,000 shares	$9.22 million	+29.5%	12.8%	0.6	$4.88
6/15/2021	1,460,000 shares	$7.08 million	+2.8%	9.9%	0.5	$4.85
5/28/2021	1,420,000 shares	$5.99 million	-15.0%	9.6%	2	$4.22
5/14/2021	1,670,000 shares	$6.76 million	+17.6%	11.3%	2.2	$4.05
4/30/2021	1,420,000 shares	$6.75 million	-15.0%	9.6%	1.4	$4.75
4/15/2021	1,670,000 shares	$7.41 million	+11.3%	11.7%	1.3	$4.44
3/31/2021	1,500,000 shares	$7.19 million	+14.5%	10.5%	1	$4.79
3/15/2021	1,310,000 shares	$7.81 million	-8.4%	9.2%	0.7	$5.96
2/26/2021	1,430,000 shares	$8.58 million	-24.3%	9.9%	0.9	$6.00
2/12/2021	1,890,000 shares	$13.89 million	-2.6%	12.7%	1.2	$7.35
1/29/2021	1,940,000 shares	$10.50 million	+84.8%	14.6%	1.4	$5.41
1/15/2021	1,050,000 shares	$5.47 million	-40.3%	7.9%	1	$5.21
12/31/2020	1,760,000 shares	$8.92 million	+64.5%	13.2%	2.2	$5.07
12/15/2020	1,070,000 shares	$30.76 million	+11.6%	8.0%	5.9	$28.75
11/30/2020	958,800 shares	$25.36 million	-10.4%	7.2%	5.7	$26.45
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad) Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late.
11/15/2020	1,070,000 shares	$22.89 million	-3.6%	8.0%	7.4	$21.39
10/30/2020	1,110,000 shares	$25.09 million	-0.9%	8.7%	9.3	$22.60
10/15/2020	1,120,000 shares	$28.84 million	-3.5%	8.7%	11.6	$25.75
9/30/2020	1,160,000 shares	$27.91 million	-4.1%	9.3%	13.4	$24.06
9/15/2020	1,210,000 shares	$34.51 million	-11.0%	9.7%	13.5	$28.52
8/31/2020	1,360,000 shares	$36.86 million	+0.7%	10.9%	9.8	$27.10
8/14/2020	1,350,000 shares	$37.29 million	-3.6%	10.9%	8.8	$27.62
7/31/2020	1,400,000 shares	$38.40 million	+20.7%	11.4%	8.7	$27.43
7/15/2020	1,160,000 shares	$33.30 million	+11.5%	9.3%	7.3	$28.71
6/30/2020	1,040,000 shares	$37.92 million	+36.3%	8.5%	7	$36.46
6/15/2020	763,200 shares	$23.40 million	+2.6%	6.2%	5.6	$30.66
5/29/2020	743,900 shares	$19.98 million	-12.5%	6.2%	8.4	$26.86
5/15/2020	850,300 shares	$29.20 million	-3.0%	7.1%	10.3	$34.34
4/30/2020	876,800 shares	$29.11 million	+3.5%	8.4%	12.2	$33.20
4/15/2020	847,300 shares	$28.81 million	+34.0%	8.1%	11.3	$34.00
3/31/2020	632,500 shares	$21.35 million	+44.6%	6.2%	7.7	$33.75
3/13/2020	437,500 shares	$14.70 million	+4.2%	4.3%	4.8	$33.61
2/28/2020	419,900 shares	$14.89 million	+45.8%	4.1%	3.7	$35.47
2/14/2020	288,000 shares	$9.92 million	+1.6%	2.8%	2.5	$34.43
1/31/2020	283,500 shares	$9.82 million	+61.4%	2.8%	2.5	$34.65
1/15/2020	175,700 shares	$6.08 million	-21.3%	1.7%	1.5	$34.62
12/31/2019	223,200 shares	$8.61 million	No Change	2.2%	1.9	$38.58

APRE Short Interest - Frequently Asked Questions

What is Aprea Therapeutics' current short interest?: Short interest is the volume of Aprea Therapeutics shares that have been sold short but have not yet been covered or closed out. As of August 15th, traders have sold 16,700 shares of APRE short. 0.35% of Aprea Therapeutics' shares are currently sold short. Learn More on Aprea Therapeutics' current short interest.
What is a good short interest ratio for Aprea Therapeutics?: The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. APRE shares currently have a short interest ratio of 2.0. Learn More on Aprea Therapeutics's short interest ratio.
Which institutional investors are shorting Aprea Therapeutics?: As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aprea Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.
What is a good short interest percentage for Aprea Therapeutics?: Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.35% of Aprea Therapeutics' floating shares are currently sold short.
Is Aprea Therapeutics' short interest increasing or decreasing?: Aprea Therapeutics saw a increase in short interest during the month of August. As of August 15th, there was short interest totaling 16,700 shares, an increase of 36.9% from the previous total of 12,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
What is Aprea Therapeutics' float size?: Aprea Therapeutics currently has issued a total of 5,430,000 shares. Some of Aprea Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aprea Therapeutics currently has a public float of 4,820,000 shares.

How does Aprea Therapeutics' short interest compare to its competitors?: 0.35% of Aprea Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Aprea Therapeutics: Entera Bio Ltd. (0.08%), Connect Biopharma Holdings Limited (0.02%), Genelux Co. (4.56%), Genenta Science S.p.A. (0.07%), Eupraxia Pharmaceuticals Inc. (0.37%), RAPT Therapeutics, Inc. (9.94%), IO Biotech, Inc. (0.17%), Portage Biotech Inc. (0.09%), Eagle Pharmaceuticals, Inc. (4.24%), Kronos Bio, Inc. (1.79%),
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.23 billion), Aptiv PLC ($2.50 billion), Royal Caribbean Cruises Ltd. ($2.48 billion), Paychex, Inc. ($2.25 billion), Moderna, Inc. ($2.17 billion), Cencora, Inc. ($2.12 billion), Tractor Supply ($1.93 billion), Onsemi ($1.82 billion), International Paper ($1.81 billion), and Rivian Automotive, Inc. ($1.72 billion). View all of the most shorted stocks.
What does it mean to sell short Aprea Therapeutics stock?: Short selling APRE is an investing strategy that aims to generate trading profit from Aprea Therapeutics as its price is falling. APRE shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Aprea Therapeutics?: A short squeeze for Aprea Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APRE, which in turn drives the price of the stock up even further.
How often is Aprea Therapeutics' short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APRE, twice per month. The most recent reporting period available is August, 15 2024.